
Number of publications published per year by Tovar, Victoria. (Source : PubMed)

Distribution of publications types for Tovar, Victoria. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
J. Hepatol.
2010;52;4

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
J. Hepatol.
2009;51;4

Pathogenesis of hepatocellular carcinoma and molecular therapies.
Curr. Opin. Gastroenterol.
2009;25;3



Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology
2008;135;6

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Cancer Res.
2008;68;16


[Cell biology and genetics in liver cancer]
Gastroenterol Hepatol
2007;30;6
CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse.
J. Immunol.
2005;174;11

Methodology in the epidemiological research of respiratory diseases and environmental pollution.
Rev Saude Publica
2002;36;1
CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1.
J. Immunol.
2001;167;7

Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9.
Blood
2001;97;11
[ See timeline ] [ See all publications ]
means that Tovar, Victoria has 5 papers cited a least 5 times - methodology
Immunology Unit, Department of Cellular Biology and Pathology, Medical School, University of Barcelona, Spain.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.